Personalis, Inc. (PSNL)

USD 4.16

(7.77%)

Total Assets Summary of Personalis, Inc.

  • Personalis, Inc.'s latest annual total assets in 2023 was 225.09 Million USD , down -23.1% from previous year.
  • Personalis, Inc.'s latest quarterly total assets in 2024 Q1 was 195.27 Million USD , down -13.25% from previous quarter.
  • Personalis, Inc. reported annual total assets of 292.7 Million USD in 2022, down -26.18% from previous year.
  • Personalis, Inc. reported annual total assets of 396.52 Million USD in 2021, up 61.95% from previous year.
  • Personalis, Inc. reported quarterly total assets of 195.27 Million USD for 2024 Q1, down -13.25% from previous quarter.
  • Personalis, Inc. reported quarterly total assets of 272.18 Million USD for 2023 Q1, down -7.01% from previous quarter.

Annual Total Assets Chart of Personalis, Inc. (2023 - 2017)

Historical Annual Total Assets of Personalis, Inc. (2023 - 2017)

Year Total Assets Total Assets Growth
2023 225.09 Million USD -23.1%
2022 292.7 Million USD -26.18%
2021 396.52 Million USD 61.95%
2020 244.84 Million USD 55.66%
2019 157.29 Million USD 277.47%
2018 41.67 Million USD 24.15%
2017 33.56 Million USD 0.0%

Peer Total Assets Comparison of Personalis, Inc.

Name Total Assets Total Assets Difference
Aclaris Therapeutics, Inc. 197.4 Million USD -14.029%
Biodesix, Inc. 99.09 Million USD -127.152%
bioAffinity Technologies, Inc. 8.22 Million USD -2637.914%
Castle Biosciences, Inc. 477.81 Million USD 52.89%
DarioHealth Corp. 96.38 Million USD -133.532%
Exact Sciences Corporation 6.47 Billion USD 96.522%
IDEXX Laboratories, Inc. 3.25 Billion USD 93.095%
Illumina, Inc. 10.11 Billion USD 97.774%
Intelligent Bio Solutions Inc. 13.77 Million USD -1533.654%
iSpecimen Inc. 15.81 Million USD -1322.954%
Standard BioTools Inc. 323.06 Million USD 30.324%
23andMe Holding Co. 395.16 Million USD 43.037%
Medpace Holdings, Inc. 1.65 Billion USD 86.414%
NeoGenomics, Inc. 1.68 Billion USD 86.611%
Inotiv, Inc. 856.53 Million USD 73.72%
Psychemedics Corporation 13.27 Million USD -1596.3%
Prenetics Global Limited 254.17 Million USD 11.438%
Precipio, Inc. 18.1 Million USD -1143.572%
RadNet, Inc. 2.88 Billion USD 92.202%
Sotera Health Company 3.13 Billion USD 92.809%
Star Equity Holdings, Inc. 86.97 Million USD -158.812%
Exagen Inc. 56.94 Million USD -295.299%
Natera, Inc. 1.45 Billion USD 84.552%
Aspira Women's Health Inc. 6.26 Million USD -3494.682%
Neogen Corporation 4.58 Billion USD 95.09%
Myriad Genetics, Inc. 1.19 Billion USD 81.221%
ICON Public Limited Company 16.98 Billion USD 98.675%
Bionano Genomics, Inc. 214.4 Million USD -4.988%
CareDx, Inc 484.61 Million USD 53.551%
Check-Cap Ltd. 25.01 Million USD -799.784%
Twist Bioscience Corporation 776.4 Million USD 71.007%
Guardant Health, Inc. 1.78 Billion USD 87.399%
BioNexus Gene Lab Corp. 11.39 Million USD -1874.588%
Fulgent Genetics, Inc. 1.27 Billion USD 82.319%
Sera Prognostics, Inc. 95.44 Million USD -135.851%
OPKO Health, Inc. 2.01 Billion USD 88.81%
Applied DNA Sciences, Inc. 13.65 Million USD -1548.886%
Star Equity Holdings, Inc. 86.97 Million USD -158.812%
MDxHealth SA 129.13 Million USD -74.317%
Prenetics Global Limited 254.17 Million USD 11.438%
ENDRA Life Sciences Inc. 6.75 Million USD -3232.753%
Mainz Biomed B.V. 15.4 Million USD -1360.825%
Trinity Biotech plc 59.43 Million USD -278.731%
Neuronetics, Inc. 115.83 Million USD -94.334%
bioAffinity Technologies, Inc. 8.22 Million USD -2637.914%